Remdesivir Intermedia CAS 946511-97-3 COVID-19 (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride
Manufacturer Commercial Supple Remdesivir et intermedia cum High Quality
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl((S)-(perfluorophenoxys)(phosphoryl)-L-alaninatum CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy) phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolitae (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermedia CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Nomen chemicum | (S)-2-Ethylbutyl 2-Aminopropanoatum Hydrochloridum |
Synonyma | Remdesivir Medius;L-Alanine 2-Ethylbutyl Ester Hydrochloride;Remdesivir Amino Ester Compone;Remdesivir Related Compound 8;Remdesivir immunditia 8 |
CAS Number | 946511-97-3 |
CATTUS Number | RF-PI298 |
Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
Formulae hypotheticae | C9H20ClNO2 |
M. Pondus | 209.71 |
Liquescens punctum | 75.0 ad 79.0℃ |
Sensitiva | Hygroscopic |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad fere album pulveris |
Damnum in Siccatio | ≤1.0% |
una immunditia | ≤0.50% |
Totalis immunditias | ≤1.0% |
Metalla gravis | ≤20ppm |
Puritas | ≥99.0% |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Remdesiviri (CAS 1809249-37-3);COVID 19 |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Shanghai Ruifu Chemical Co., Ltd. est praecipuum fabricam et supplementum (S)-2-Ethylbutyl 2-Aminopropanoate hydrochloridi (CAS 946511-97-3), typice usus est ad praeparationem Remdesiviri (CAS 1809249-37-3 ).Remdesivir, etiam GS-5734 notus, novum antivirale medicamentum in genere nucleotide analogorum a Scientiarum Gilead explicatum est, cum efficaci antivirali actione (EC50s 74 nM pro SARS-CoV et MERS-CoV in HAE cellulis).Mense Februario 2020 Remdesivir studuit experimentalem curationem COVID-XIX emergentis (covid-novi) morbi.